Antibiotice Iași Wins Award for Highest Investor Return at BVB Awards 2025

In 2024, the shareholders of Antibiotice Iași achieved remarkable success on the stock market, securing the highest investment return in recent years — approximately 90%. The spectacular surge in the company’s share value propelled it to the top of the most traded companies on the Bucharest Stock Exchange, highlighting strong investor interest and an impressive financial performance.

This achievement was officially recognized at the prestigious BVB Awards 2025 event, where Antibiotice Iași won the award for the highest return to investors within the BET-XT index. This distinction reflects the sustained efforts of the company’s team, partners, and investors who trusted the company’s development strategy. Intelligent investments and efficient management were key to achieving this exceptional result.

Another significant milestone in 2024 was the company’s inclusion in the BET index, one of the most important stock market indicators on the Bucharest Stock Exchange, starting in September. This major step solidified Antibiotice Iași’s position among the top 20 most performant companies on the Romanian capital market, demonstrating both the company’s financial stability and the market’s confidence in its ability to continue growing and innovating.

With nearly 28 years of experience on the capital market, Antibiotice Iași has managed to establish itself as a key player in the pharmaceutical sector, consistently attracting investor interest. By the end of 2024, the company reached an impressive market capitalization of over 1.7 billion RON, underlining not only its market stability but also the attractiveness of ATB shares to investors. This financial success is a clear indicator of the market’s trust in the company’s future plans and its ability to successfully tackle economic challenges.

In conclusion, 2024 was a landmark year for Antibiotice Iași, which strengthened its position on the stock market and captured investors’ attention through its outstanding financial performance. The performance of its shares and the recognition from the Bucharest Stock Exchange are proof of a solid strategy and effective management, promising a prosperous and stable future for the company and its shareholders.